Eli Lilly and Company

🇺🇸New York Stock Exchange
Back to all articles
Eli Lilly and Company stock analysis LLY overview
Bullish +75

Cramer says Apple and Eli Lilly still have room to run after post-earnings rallies

📈 The S&P 500 reached a new intraday high on Friday, driven primarily by strong gains in Apple shares.

💰 Apple's second-quarter revenue rose 17% to $111.2 billion, surpassing analyst estimates of $109.7 billion.

🔄 Jim Cramer described the market rally as "the comeback of the Mag Seven" following recent positive earnings from Amazon and Alphabet.

📱 Apple reported an all-time high in its installed base of active devices across all categories and geographies, exceeding 2.5 billion units.

💬 Cramer advised investors to "own" Apple stock rather than trade it after praising the company's earnings call as bringing him "pure joy".

⬆️ Shares of Eli Lilly rose another 3% on Friday following a significant post-earnings rally from Thursday's session.

🧪 Eli Lilly reported an extraordinary quarter with revenue surging 56% year-over-year to $19.8 billion, beating top and bottom-line estimates.

⚠️ Cramer warned investors against selling Eli Lilly too soon despite the recent price increase, calling the move risky if executed now.

🏛️ The CNBC Investing Club is long on both Apple (APPL) and Eli Lilly (LLY), among other major tech and healthcare stocks.

🤖 Cramer's charitable trust follows a strict waiting period of 45 minutes after issuing trade alerts before executing any buy or sell orders.

📰 If Cramer discusses a stock on CNBC TV, his trust waits an additional 72 hours after the alert before acting on it.

⛽ Oil prices fell on Friday as Iran reportedly shared an updated peace proposal to mediators in Pakistan.

🕊️ Hope for a potential agreement between Iran and the US to end the war sparked the decline in energy commodity prices.

📅 This recap covers key moments from Friday's "Morning Meeting" livestream held at 10:20 a.m. ET with Jim Cramer.

📉 Meta and Microsoft reported earnings beats on Wednesday but failed to generate the same investor enthusiasm as Apple.

Bullish Signals
  • Eli Lilly saw an extraordinary quarter with revenue surging 56% year-over-year to $19.8 billion, representing massive top and bottom-line beats.
  • Shares of Eli Lilly jumped another 3% following a nearly 10% post-earnings rally, demonstrating continued strong investor confidence.
  • Jim Cramer emphasized that the stock has 'lots of room to run' and advised investors not to sell too soon, noting the exceptional performance.
  • The CNBC Investing Club holds positions in Eli Lilly (LLY), signaling bullish sentiment from Jim Cramer based on recent results.
Risk Factors
  • The article relies heavily on optimistic commentary from Jim Cramer regarding Apple and Eli Lilly without addressing any potential downside risks or valuation concerns.
  • Jim Cramer explicitly advises investors to 'own' Apple rather than 'trade it', which may discourage profit-taking in a potentially overvalued market after recent rallies.
  • Despite the positive earnings, Meta and Microsoft reported beats that failed to win over investors, indicating broader market skepticism towards Big Tech valuations.
  • The article includes standard investment disclaimers stating that no profit is guaranteed and no fiduciary duty exists, which serves as a risk warning for investors following Cramer's advice.
  • Cramer's charitable trust holds positions in several tech giants (GOOGL, META, MSFT) mentioned with mixed performance, suggesting concentration risk in the sector.
Full Analysis
Jim Cramer highlighted on Friday that both Apple and Eli Lilly still possess significant upside potential following their recent post-earnings rallies. The S&P 500 reached a fresh intra-day high, driven largely by gains in Apple, which is part of the "Mag Seven" comeback according to Cramer. On Thursday, Apple reported a near-perfect quarter with second-quarter revenue rising 17% to $111.2 billion, surpassing the LSEG estimate of $109.7 billion. The company also issued strong guidance, noting that its installed base of active devices has reached an all-time high exceeding 2.5 billion across all product categories and geographic areas. Cramer advised investors to hold Apple rather than trade it, describing the earnings call as a source of "pure joy." He specifically recommended against selling Eli Lilly after its shares jumped another 3% following a nearly 10% rally on Thursday. Cramer characterized Lilly's quarter as "extraordinary," citing massive top and bottom-line beats where revenue surged 56% year-over-year to $19.8 billion. He stated, "If you sell Lilly, you're going to be selling it too soon, no matter what you do." In terms of market context, while Meta and Microsoft also reported earnings beats on Wednesday, they did not secure the same investor enthusiasm as Apple and Amazon, which had beaten expectations the previous day. Additionally, oil prices were noted to have fallen following news that Iran reportedly responded to Pakistani mediators with an updated peace proposal. Jim Cramer's Charitable Trust maintains long positions in various Club holdings including LLY, GOOGL, META, MSFT, APPL, and AMZN. He follows specific protocols for trading within his charitable trust, waiting 45 minutes after sending a trade alert before executing any buy or sell order for Apple and Eli Lilly. If a stock is discussed on CNBC television, Cramer adheres to a 72-hour waiting period between issuing a trade alert and executing the trade. These disclosures come with standard terms and conditions noting that no fiduciary obligation exists and no specific profit outcome is guaranteed for subscribers receiving trade alerts via the CNBC Investing Club.